Mean high-dose L-thyroxine treatment is efficient and safe to achieve a normal IQ in young adult patients with congenital hypothyroidism
Aleksander Pe(Charité - Universitätsmedizin Berlin), Heiko Krude(Humboldt-Universität zu Berlin), Michaela Brückner-Spieler(Charité - Universitätsmedizin Berlin), Peter Kühnen(Humboldt-Universität zu Berlin), Annette Grüters(Unknown), Dirk Schnabel(Humboldt-Universität zu Berlin), Oliver Blankenstein(Inserm), Maria E. Craig(New South Wales Department of Health), W Stablein(Charité - Universitätsmedizin Berlin), Erwin Lankes(Charité - Universitätsmedizin Berlin), Andrea Ernert(Institute for Medical Informatics and Biostatistics), Stoehr Am(Charité - Universitätsmedizin Berlin)
Cited by 2
Related Papers
Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
|Nature Genetics|1998|1.7k
Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation
|The Lancet|2004|707
European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism
|The Journal of Clinical Endocrinology & Metabolism|2014|569
PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis
|Nature Genetics|1998|503
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
|New England Journal of Medicine|2016|480